Stay updated with breaking news from Naomi Eichenbaum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN DIEGO, July 20, 2023 -- Travere Therapeutics, Inc. today announced it will report second quarter 2023 financial results on Thursday, August 3, 2023, after the close of the U.S. financial...
• Mirum to acquire all of Travere’s rights and assets related to Cholbam® and Chenodal® • Travere to receive up to $445 million with $210 million upfront and up to $235 million in...
SAN DIEGO, July 11, 2023 -- Travere Therapeutics, Inc. today announced that on July 10, 2023, the Compensation Committee of its Board of Directors granted inducement equity grants to three new...
SAN DIEGO, June 14, 2023 -- Travere Therapeutics, Inc. today announced that on June 10, 2023, the Compensation Committee of its Board of Directors granted inducement equity grants covering an... | June 14, 2023
FinancialContent fully hosted finance channel